BRTX-100 is the first and only stem cell product candidate cleared to be evaluated in the cervical degenerative disc disease setting - - IND clearance expands Company's advanced clinical pipeline for ...

BRTX-100 is the first and only stem cell product candidate cleared to be evaluated in the cervical degenerative disc disease ...

BioRestorative Therapies (BRTX) announced the U.S. Food and Drug Administration has cleared its Investigational New Drug application for ...